August 9, 2024

Recent overdose deaths raise fears for people in prison

Naloxone must be made available to save lives


The recent concern about fatal opioid overdose from nitazenes in the illicit drug supply has raised fears for many prison experts. People who are in prison are not afforded the same protections as people in the community while recent release from prison is also an extremely vulnerable time in which many people experience fatal overdose.


We, a coalition of health practitioners, harm reduction advocates and experts, are today calling for expanded access to naloxone in prisons to protect against fatal overdoses from nitazenes and other synthetic opioids. In order to prevent avoidable deaths, we are calling on each state and territory government to immediately:


  • Provide training to custodial officers to recognise overdose and administer naloxone
  • Ensure naloxone is accessible to custodial officers to promptly and effectively respond to overdose
  • Ensure that naloxone and naloxone training is routinely offered to all people exiting prison.


Nitazenes are a synthetic opioid that can be hundreds of times stronger than heroin and can be fatal even in very small amounts.1  They have been linked to an increasing number of overdoses and deaths in Australia this year2 and have also been connected to at least 15 overdose deaths in prisons in the UK.3 With new national data released last week on wastewater analysis,4 and a NSW Drug Summit now scheduled for later this year, it is a reminder that we should be addressing harms of illicit drug use.


“Nitazenes in prisons are a disaster waiting to happen,” says the CEO of the Australian Alcohol and Other Drugs Council, Ms Melanie Walker. “We know nitazenes are in the illicit drug supply in Australia and it is only a matter of time before they enter prisons. People in prison have a higher rate of injecting drug use than the general population and despite efforts to prevent drug supply in prison, the evidence shows that drug use is still common. Nitazenes and other synthetic novel drugs are significantly more difficult to detect than “traditional” opioid drugs such as heroin. Prisons are currently ill equipped to handle a potential influx of these lethal substances,” Ms Walker continued.


A key tool in the fight against opioid overdose is naloxone, a life-saving medication which can temporarily reverse an opioid overdose, including from nitazenes. It is available in Australia as an easy-to-use nasal spray or injection. The Australian Government Department of Health and Aged Care recommends that naloxone be administered to anyone overdosing from opioids.5
However, naloxone is not readily available in prisons in Australia. Naloxone is generally only administered by healthcare staff. As noted by Ms Walker, this severely limits access for people who need it, when they need it:


“Health staff are not always available or accessible to people in prison. If we are going to save lives, we must find ways to get naloxone to people in prison when they need it. One important step that all prisons could take right now is for custodial officers to have ready access to naloxone and be trained in how to recognise and respond to overdose. Many police officers
across Australia now regularly carry and administer naloxone. Custodial officers should be trained in the same way.”


The period following release from prison is an especially high-risk time for overdose, with opioid overdose deaths up to twenty times higher for people leaving prison than the general population.6 Ensuring that naloxone and training in how to use it is provided to people in prison before release is a key strategy in combatting overdose deaths.7  However, provision is currently patchy as not every state and territory provides training or access to naloxone for people exiting prison.


“There are too few people getting naloxone at the time they leave prison,” says Ele Morrison, Deputy CEO of the Australian Injecting and Illicit Drug Users League (AIVL).


“To save lives, training and access to naloxone must be expanded and improved within all prisons. As a first step we call on governments to implement these measures immediately. But
we also encourage them to look for ways to implement harm reduction in prison.”


-ENDS-


Signatories to media statement

  • Mary Harrod, CEO, NSW Users and Aids Association (NUAA)
  • Geoff Davey, CEO, QuIHN
  • Professor Alison Ritter AO, Director, Drug Policy Modelling Program (DPMP), UNSW
  • Liz Barrett, Chair, Harm Reduction in Prisons Working Group
  • Melanie Walker, CEO, Australian Alcohol and Other Drugs Council (AADC)
  • Dr Lise Lafferty, Senior Research Fellow, Centre for Social Research in Health (CSRH), UNSW
  • Sione Crawford, CEO, Harm Reduction Victoria
  • Professor Kate Dolan, Harm Reduction Australia, UNSW
  • John Didlick, Policy Analyst, Hepatitis Australia
  • Paul Dessauer, CEO, Peer Based Harm Reduction WA
  • Brent Bell, CEO, Hepatitis WA
  • Steven Drew, CEO, Hepatitis NSW
  • Ele Morrison, Deputy CEO, Australian Injecting and Illicit Drug Users League (AIVL)

 

1. Kozell et al, 2024, Pharmacologic characterization of substituted nitazenes at μ, κ, andΔ opioidreceptorssuggestshighpotentialfortoxicity,
TheJournalofPharmacologyandExperimentalTherapeutics, 
https://doi.org/10.1124/jpet.123.002052
2.
 NSW Health , 29 May 2024 
The Age, 4 July 2024: 
https://www.theage.com.au/national/victoria/synthetic-opioid-detected-in-four-found-dead-in-broadmeadows-20240704-p5jr1k.html
3. 
Super-strength synthetic opioids causing UK inmate deaths | Matrix Diagnostics
4. ACIC, 11 July 2024, 
https://www.acic.gov.au/sites/default/files/2024-07/National%20Wastewater%20Drug%20Monitoring%20Program%20%E2%80%93%20Report%2022_0.pdf
5. 
About opioid overdose and adverse reactions | Australian Government Department of Health and Aged Care
6.
 https://www.aihw.gov.au/reports/prisoners/the-health-of-people-in-australias-prisons-2022/contents/deaths/deaths-following-release-from-prison; Borschmann, R. (2024) The Lancet

Media Contacts

Melanie Walker, CEO, AADC, 0438 430 963
Ele Morrison, Deputy CEO, AIVL, 0433 940 433


By Rita Francis March 13, 2026
A toolkit to support organisations implement the Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings (3rd edition) into practice is now available. Developed by researchers from the Matilda Centre at the University of Sydney in collaboration with key stakeholders, including AOD organisational leaders and workers, people with lived experience and loved ones, with funding from Australian Government Department of Health, Disability and Ageing, the Guidelines implementation toolkit aims to assist organisational leaders to identify and address the following: evidence-to-practice gaps in relation to Guidelines recommendations; barriers to the implementation of Guidelines recommendations; implementation strategies and tools to address identified barriers; and processes for implementing and evaluating change. What is the toolkit? The Toolkit guides organisational leaders through a five-step implementation process for putting Guidelines recommendations into practice. Steps 1-4 inform the development and evaluation of an implementation work plan described in Step 5. Each step is accompanied by: i) guidance on how to complete the step; ii) an example of the step being completed in practice; and iii) implementation tools. The toolkit is designed to be flexible and adaptable to individual AOD treatment settings, and guidance and tools do not need to be used prescriptively. Instead, organisational leaders can use their experience, judgement and expertise to apply the toolkit within their local context. Who is the toolkit for? The toolkit has been developed for people working within AOD treatment settings who have the capacity to influence change, such as organisational leaders, service managers, clinic directors, quality assurance and improvement officers.
By Rita Francis March 13, 2026
19–21 August 2026
By Rita Francis March 13, 2026
8-11 November 2026
By Rita Francis March 13, 2026
Yilli Rreung Housing is pleased to announce the launch of our Homes Together – Tenant Sustainability Service (TSS) Program. Please see below for more information about the program and the support they offer. For more information or to make a referral, please email TSS@yillihousing.com.au Click here for the referral form. Please complete and return via email.
By Rita Francis July 10, 2025
The Alcohol and Drug Foundation (ADF), in collaboration with SHARC and Harm Reduction Victoria, has launched a powerful new resource focused on Lived and Living Experience (LLE) in the Alcohol and Other Drug (AOD) sector. As momentum grows across Australia for meaningful and ongoing LLE involvement, this resource highlights the vital role that people with lived or living experience play across all areas of health and social support, including strategy and policy development, research, education and training, leadership, program design and service delivery. This new resource offers practical insights and guidance on: What LLE is and why it matters The variety of roles people with LLE hold across Australia How their unique expertise can drive better outcomes for individuals and communities Key considerations for engaging LLE meaningfully and ethically in your work Whether you're a service provider, policymaker, educator or working in program design, this resource is a must-read to ensure your approach is informed, inclusive and reflective of real-world experience. View the resources here .
By Rita Francis July 9, 2025
NCCRED recently hosted a webinar titled “ Digital interventions for methamphetamine use and First Nations people ”. The session began with an overview of a four-phase project with Aboriginal and Torres Strait Islander populations. During the data collection phase, qualitative and quantitative data were gathered from 736 participants aged 16 and above (median age 34), 60% of whom identified as Aboriginal and/or Torres Strait Islander. These insights informed the development of community-led prevention strategies and a web-based app, “Wada Wanti: Leave the Ice Alone”. The app content is based on evidence-based approaches including cognitive-behavioural therapy, motivational interviewing, emotional regulation techniques and relaxation strategies. The digital interventions can be used independently or integrated by workers in a range of service settings, including primary care and AOD treatment sessions.  The webinar concluded with a panel discussion and Q&A session. The recorded webinar is available here .
By Rita Francis July 9, 2025
Barod, an AOD service based in Wales (United Kingdom), recently published a guide titled “Why language matters” which was developed alongside people with lived and living experience of substance use. The authors note that when it comes to substance use, language can either reinforce stigma or foster understanding. They explain that dehumanising and derogatory words like “addict”, “clean”, or “chaotic” can carry judgment, shame, and blame — and can stop people from seeking the support they need. The authors suggest when we choose our words with care, we help create a culture of dignity, inclusion, and hope. This guide provides a list of language to avoid, why, and acceptable alternatives to use. Although this guide was developed in Wales, we think much of the content applies to the Australian context. Visit the Barod website and download the guide here .
By Rita Francis July 9, 2025
This study titled “Parent substance use and child-to-parent violence: A brief report” investigated the association between parental substance use and substance involved child to parent violence (SU-CPV) i.e. the young person is influenced by a substance. They found parental alcohol use was associated with an increased likelihood of SU-CPV. They suggest parental behaviours may influence the young person's behaviour, and this may be exacerbated by the disinhibiting impact of alcohol and unpredictability within the home environment. They also discuss that parental alcohol use could be a coping strategy for parents experiencing SU-CPV. Access the report here - Parent substance use and child-to-parent violence: A brief report
By Rita Francis July 9, 2025
Tobacco use in Australia – including among young people - is at its lowest level in decades, largely due to effective public health strategies. However, a recent article in The Guardian suggests that the twice-yearly increases in tobacco excise may have reached the limit of their effectiveness. Rather than further reducing smoking rates, these ongoing tax increases may be contributing to the growth of the illicit tobacco market. The article examines the impactof continued excise increases and highlights the growing challenge posed by illicit tobacco sales in Australia, raising important questions about the future direct of tobacco control efforts. To read the full article, go to “Tobacco excise ha s passed a ‘tipping point’ and is fuelling black market, economists warn”
By Rita Francis July 9, 2025
NAIDOC week starts this Sunday, 6th of July. It is an opportunity to recognise and celebrate the history, culture and achievements of Aboriginal and Torres Strait Islander peoples. This year’s theme, "The Next Generation: Strength, Vision & Legacy," celebrates both achievements of the past and the bright future ahead, empowered by the strength of young leaders, the vision of communities, and the legacy of ancestors. 2025 also marks NAIDOC’s 50th year! To learn more about NAIDOC week, download promotional materials, and find events happening in your area, go to NAIDOC Week 2025 .
Show More